| Paula Kaye Beck, OTR | |
|
2016 Oklahoma Ave, Sikeston, MO 63801 | |
| (573) 931-1766 | |
| (877) 706-6877 |
| Full Name | Paula Kaye Beck |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2016 Oklahoma Ave, Sikeston, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508066978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 002567 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Paula Kaye Beck, OTR 2016 Oklahoma Ave, Sikeston, MO 63801 Ph: (573) 472-1575 | Paula Kaye Beck, OTR 2016 Oklahoma Ave, Sikeston, MO 63801 Ph: (573) 931-1766 |
News Archive
Four CGIAR scientists, Dr. Howarth Bouis (HarvestPlus), Dr. Jan Low (CIP), Maria Andrade (CIP), and Robert Mwanga (CIP) will be awarded the World Food Prize tonight for their combined success in improving nutrition and health through biofortified crops.
Each year many thousands of Africans contract sleeping sickness. The cause is a unicellular parasite, a trypanosome, which is transmitted by the bite of tsetse flies. First the parasite multiplies in blood and lymph, while evading the human immune system. It then lodges in organs like heart and kidneys and finally in the brain. Patients become disoriented, their sleeping pattern disintegrates and they get motor and mental problems.
In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.
Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFY (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder, with or without psychotic features in pediatric patients (10 to 17 years old).
More than £6M of funding has been awarded to enhance the development of biopharmaceuticals. In total £6.5M will fund 12 projects to deliver commercially important results, such as industrial-scale production of antibodies, stem cell preservation at room temperature, biopharmaceutical production using microbes and commercial scale stem cell therapy.
› Verified 3 days ago
Jane Kiunisala Apurado, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 821 Auburn Dr, Sikeston, MO 63801 Phone: 573-718-4368 | |
Laura Nicole Duggan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 | |
Julie C Ail, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 Fax: 573-472-0409 | |
Mrs. Angela Christine Vandenberghe, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 Fax: 573-472-0409 | |
Brittan Rachel Bossert, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 Fax: 573-472-0409 | |
Taylor Ann Brotherton, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 113 Holmes Dr, Sikeston, MO 63801 Phone: 573-380-5557 | |
Miss Taralynn Sandker, M.S. OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 Fax: 573-472-0406 |